William Blair & Company
BMY icon

William Blair & Company’s Bristol-Myers Squibb BMY Stock Holding History

William Blair & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$56K – 1376
2017
Q2 		$56K Buy
+1,000
New +$54.4K ﹤0.01% 1463

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair & Company's BMY Position: Q2 2026 in Review

William Blair & Company reduced its Bristol-Myers Squibb (BMY) stake by 0.34% in Q2 2026, selling an estimated $81.1K and leaving 416,247 shares worth $24M. The position accounts for 0.06% of the portfolio, ranked #231.

William Blair & Company first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $278M in Q2 2015. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • William Blair & Company held 416,247 shares of Bristol-Myers Squibb worth $24M as of Q2 2026.
  • William Blair & Company sold 1,412 Bristol-Myers Squibb shares in Q2 2026, an estimated $81.1K.
  • Bristol-Myers Squibb made up 0.06% of William Blair & Company's portfolio in Q2 2026, its #231 holding.
  • William Blair & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • William Blair & Company's Bristol-Myers Squibb position peaked at $278M in Q2 2015.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.